XML 19 R7.htm IDEA: XBRL DOCUMENT v3.7.0.1
Consolidated Statements of Cash Flows (Unaudited) - USD ($)
$ in Thousands
3 Months Ended
Jan. 01, 2017
Mar. 31, 2017
Mar. 31, 2016
Cash flows from operating activities:      
Net income (loss)   $ (32,301)  
Adjustments to reconcile net loss to net cash used in operating activities:      
Depreciation and amortization   31,606  
Impairment expense    
Inventory write-down    
Deferred income taxes    
Provision for doubtful accounts, net of write-offs   576  
Equity in earnings from unconsolidated affiliate   182  
(Gain) loss on disposal of assets   (6,056)  
Share-based compensation expense   16,882  
Amortization of deferred financing costs   153  
Accretion of original issue discount    
Reorganization items, net    
Changes in operating assets and liabilities:      
Accounts receivable   (94,514)  
Inventory   (5,006)  
Prepaid and other current assets   5,675  
Accounts payable   8,525  
Payroll and related costs and accrued expenses   (594)  
Liabilities subject to compromise    
Income taxes payable   (2,694)  
Other   (336)  
Net cash used in operating activities   (77,902)  
Cash flows from investing activities:      
Purchases of and deposits on property, plant and equipment   (11,585)  
Proceeds from disposal of property, plant and equipment   1,502  
Proceeds from divestiture of non-core service lines   26,698  
Net cash provided by (used in) investing activities   16,615  
Cash flows from financing activities:      
Proceeds from revolving debt    
Payments on revolving debt    
Payments on term loans    
Payments on DIP Facility    
Payments of capital lease obligations    
Financing costs   (206)  
Proceeds from issuance of common shares for rights offering   0  
Employee tax withholding on restricted stock vesting   (3,773)  
Excess tax expense from share-based compensation    
Net cash provided by (used in) financing activities   (3,979)  
Effect of exchange rate changes on cash   (858)  
Net increase (decrease) in cash and cash equivalents   (66,124)  
Cash and cash equivalents, beginning of period $ 181,242 181,242  
Cash and cash equivalents, end of period   115,118  
Predecessor [Member]      
Cash flows from operating activities:      
Net income (loss) 298,582   $ (428,412)
Adjustments to reconcile net loss to net cash used in operating activities:      
Depreciation and amortization   58,953
Impairment expense   381,694
Inventory write-down   1,267
Deferred income taxes (4,613)   (94,148)
Provision for doubtful accounts, net of write-offs   508
Equity in earnings from unconsolidated affiliate   156
(Gain) loss on disposal of assets   3,202
Share-based compensation expense   11,923
Amortization of deferred financing costs   2,279
Accretion of original issue discount   2,079
Reorganization items, net (315,626)  
Changes in operating assets and liabilities:      
Accounts receivable   96,247
Inventory   817
Prepaid and other current assets   6,119
Accounts payable   (70,004)
Payroll and related costs and accrued expenses (1,436)   (6,701)
Liabilities subject to compromise (33,000)  
Income taxes payable   5,556
Other   (1,106)
Net cash used in operating activities (56,093)   (29,571)
Cash flows from investing activities:      
Purchases of and deposits on property, plant and equipment   (18,667)
Proceeds from disposal of property, plant and equipment   12,009
Proceeds from divestiture of non-core service lines  
Net cash provided by (used in) investing activities   (6,658)
Cash flows from financing activities:      
Proceeds from revolving debt   174,000
Payments on revolving debt   (8,000)
Payments on term loans   (2,650)
Payments on DIP Facility (25,000)  
Payments of capital lease obligations   (810)
Financing costs (2,248)  
Proceeds from issuance of common shares for rights offering 200,000  
Employee tax withholding on restricted stock vesting   (315)
Excess tax expense from share-based compensation   (5,592)
Net cash provided by (used in) financing activities 172,752   156,633
Effect of exchange rate changes on cash   (2,769)
Net increase (decrease) in cash and cash equivalents 116,659   117,635
Cash and cash equivalents, beginning of period 64,583 $ 64,583 25,900
Cash and cash equivalents, end of period $ 181,242   $ 143,535